FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Pivot Pharmaceuticals

  • Home
  •  | 
  • Tag Archives: "Pivot Pharmaceuticals"

Pivot Pharma Signs Contract Manufacturing Agreement with Growpacker Inc.

Pivot Pharma Signs Contract Manufacturing Agreement with Growpacker Inc.
Jan. 28, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has entered into a strategic Contract Manufacturing Agreement ("the Agreement") with Growpacker Inc. ("Growpacker") to produce Pivot's differentiated and patented topical gels, creams and beverages for the California cannabis market.
Read more

Pivot Announces Completion of Definitive Agreement with Cartagena Inc.

Pivot Announces Completion of Definitive Agreement with Cartagena Inc.
Dec. 18, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to report that it has completed the previously announced transaction to create a Joint Venture Corporation ("Pivot-Cartagena Joint Venture Inc." or "JVC") with Cartagena Leaf Inc., a subsidiary of Mexico-based Licorera Del Sur.
Read more

Pivot Naturals LLC Awarded Temporary License to Manufacture Adult and Medicinal Use Cannabis from the California Department of Public Health

Pivot Naturals LLC Awarded Temporary License to Manufacture Adult and Medicinal Use Cannabis from the California Department of Public Health
Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot") is pleased to announce that it has received a Temporary License from the California Department of Public Health to manufacture adult and medicinal use cannabis-infused products in its Costa Mesa, California facility. Receipt of this license brings Pivot one step closer to production, generating revenue, and bringing its brands to the California ingestible and edible cannabis market.
Read more